The invention relates to a
synbiotics of
bacillus licheniformis and
oligosaccharide class prebiotics and a composite and a formulation thereof, being characterized in that the
synbiotics comprises
bacillus licheniformis medical live bacterial
powder and the
oligosaccharide class prebiotics, wherein the
bacillus licheniformis medical live bacterial
powder contains live
bacteria about 30 billion /
gram; the weight ratio of the bacillus licheniformis medical live bacterial
powder to the
oligosaccharide class prebiotics is 1:1 to 76; the weight ratio of the medical live bacterial powder of the composite, the oligosaccharide class prebiotics and auxiliary materials is as follows: 1.25-5 percent of the bacillus licheniformis medical live bacterial powder, 5-95 percent of the oligosaccharide class prebiotics, 20-50 percent of preferable oligosaccharide class prebiotics, 30-65 percent of diluting agents, 1-20 percent of bonding agents, 1-15 percent of disintegrating agents, 0.1-3 percent of lubricating agents, 1-10 percent of
coating agents, 0.01-0.1 percent of
flavoring agents, 0.0001-0.001 percent of
coloring agents, and 0.1-15 percent of
suspending agents. The
synbiotics composite is prepared into oral common tablets,
oral cavity disintegration tablets, dispersing tablets, enteric-
coated tablets, granular formulation, enteric-coated granular formulation, capsules, enteric-coated capsules, dry supensoid agents and external tablets according to a conventional process; and an
in vitro test shows that each formulation can promote the growth and the
reproduction of the synbiotics of bacillus licheniformis, restrain the growth of harmful
bacteria, enhance the immunizing power of parasitifers, reduce
diarrhea and enhance the health care.